FIORETTO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 11.528
EU - Europa 1.187
AS - Asia 709
SA - Sud America 5
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.436
Nazione #
US - Stati Uniti d'America 11.522
CN - Cina 556
IT - Italia 292
FI - Finlandia 277
DE - Germania 168
SE - Svezia 163
UA - Ucraina 158
GB - Regno Unito 75
IN - India 62
VN - Vietnam 44
FR - Francia 15
IE - Irlanda 15
NL - Olanda 11
TH - Thailandia 8
JP - Giappone 7
CA - Canada 5
HK - Hong Kong 5
PH - Filippine 5
TR - Turchia 5
SG - Singapore 4
LU - Lussemburgo 3
TW - Taiwan 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
EC - Ecuador 2
GA - Gabon 2
HR - Croazia 2
KR - Corea 2
MY - Malesia 2
A1 - Anonimo 1
AR - Argentina 1
AT - Austria 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.436
Città #
Fairfield 2.126
Woodbridge 1.297
Houston 1.103
Ann Arbor 863
Ashburn 853
Cambridge 721
Seattle 709
Chandler 707
Wilmington 693
Jacksonville 652
Princeton 337
San Diego 185
Medford 154
Nanjing 122
Beijing 120
Des Moines 110
Roxbury 107
Helsinki 102
Padova 85
Boardman 72
Guangzhou 54
Pune 45
Dong Ket 44
Hebei 36
Shenyang 36
Jiaxing 29
Tianjin 29
Nanchang 28
Norwalk 28
New York 19
Milan 18
Changsha 17
Redwood City 15
Dublin 14
Rome 14
Jinan 13
London 13
Rovigo 12
Borås 11
Kharkiv 11
Kilburn 10
Zhengzhou 9
Chicago 8
Florence 7
Rockville 7
Acton 6
Altavilla Vicentina 5
Gavirate 5
Hefei 5
Modena 5
Ogden 5
Shanghai 5
Delhi 4
Groningen 4
Hangzhou 4
Lendinara 4
Ningbo 4
Paris 4
Selvazzano Dentro 4
Singapore 4
Taizhou 4
Toyotamanaka 4
Venice 4
Washington 4
Bari 3
Bologna 3
Chengdu 3
Chiswick 3
Duncan 3
Falls Church 3
Haikou 3
Indiana 3
Kunming 3
Lanzhou 3
Leawood 3
Luxembourg 3
Mumbai 3
Rivignano 3
San Francisco 3
Vicenza 3
Wuhan 3
Acquaviva Picena 2
Arcade 2
Arcole 2
Chennai 2
Chieti 2
Costa Mesa 2
Dalmine 2
Frankfurt am Main 2
Guayaquil 2
Hanover 2
Hong Kong 2
Hounslow 2
Islington 2
Jersey City 2
Lappeenranta 2
Libreville 2
Munich 2
Naples 2
Novoli 2
Totale 11.818
Nome #
Modifications of Resting Energy Expenditure After Sleeve Gastrectomy 186
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. 157
SGLT2 Inhibitors and the Diabetic Kidney 136
Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment 135
Incidence and Predictors of Hypoglycemia 1 Year After Laparoscopic Sleeve Gastrectomy 130
Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit. 113
Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. 112
Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable 111
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 104
Impaired Response To Angiotensin-ii In Type-1 (insulin-dependent) Diabetes-mellitus - Role of Prostaglandins and Sodium-lithium Countertransport Activity 103
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects 102
Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment 102
Patterns of renal injury in NIDDM patients with microalbuminuria 101
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus 101
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 101
High-protein diet: a barrier for sodium-glucose co-transporters 2 inhibitors nephroprotective effects? 101
Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive type 2 diabetic patients with microalbuminuria: DIAL study. 98
null 98
The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: A neutral viewpoint. 96
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 96
Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. 94
Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. 93
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 92
Mechanisms linking empagliflozin to cardiovascular and renal protection 91
Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism. 89
Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions 89
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 88
Biological Variability of Estimated GFR and Albuminuria in CKD 88
Ketone bodies increase glomerular filtration rate in normal man and in patients with Type 1 (insulin-dependent) diabetes mellitus 87
The kidney in diabetes: dynamic pathways of injury and repair. 86
Type I insulin-dependent diabetic patients show an impaired renal hemodynamic response to protein intake. 85
Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients 85
Overall quality of care predicts the variability of key risk factors for complications in type 2 diabetes: An observational, longitudinal retrospective study 85
Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis 85
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia 84
Renal protection in diabetes: role of glycemic control. 83
Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins. 83
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative 83
null 83
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 83
Diabetic Nephropathy 82
Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies 82
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 82
Renal structure incaucasian noninsulindependent diabetic patients. 81
Bariatric surgery improves atherogenic LDL profile by triglyceride reduction 81
The kidney in type 2 diabetes: focus on renal structure. 81
Tubular Na+ handling in type I insulin-dependent diabetics during saline and ketone body infusion 80
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes 80
Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure 80
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin dependent diabetic subjects: a deconvolution-based approach 80
Renal structure in type 2 diabetes 79
Glucose and ketone body turnover in carnitine-palmitoyl-transferase deficiency. 79
Acute phase markers of inflammation and glomerular structure in type 2 diabetic patients 79
Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. 78
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 78
Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes 78
Relationships Among Natriuresis, Atrial-natriuretic-peptide and Insulin In Insulin-dependent Diabetes 78
Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria 77
Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. 76
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? 76
Antihypertensive treatment and multifactorial approach for renal protection in diabetes 76
Histopathology of diabetic nephropathy. 76
Apparent treatment resistant hypertension, blood pressure control and the progression of chronic kidney disease in patients with type 2 diabetes 76
Reversal of lesions of diabetic nephropathy after pancreas transplantation. 75
A defect in glycogen synthesis characterizes insulin resistance in hypertensive patients with type 2 diabetes 75
Diabetic nephropathy: renal structural studies in type 1 and type 2 diabetic patients 75
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin 75
Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes 74
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience 74
Growth factors and diabetic nephropathy: kidney structure and therapeutic interventions. 73
Pathophysiology of diabetic complications. 73
Mesangial expansion in diabetic nephropathy: functional and genetic considerations. 73
Reversibility of diabetic nephropathy lesions: a new concept 73
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 73
Vascular endothelial growth factor expression in microdissected glomeruli of type 2 diabetic patients. 72
Residual microvascular risk in diabetes: unmet needs and future directions. 72
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. 72
Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. 72
Is diabetic nephropathy reversible? 71
The effect of dapagliflozin on renal function in patients with type 2 diabetes 71
Patterns of renal injury in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. 71
Role of Atrial-natriuretic-peptide In the Pathogenesis of Sodium Retention In Iddm With and Without Glomerular Hyperfiltration 71
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients 70
Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD annals initiative 70
Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients. 69
Enhancing the predictive value of urinary albumin for diabetic nephropathy 69
Reversal of diabetic nephropathy: lessons from pancreas transplantation. 69
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 69
Effects of atrial natriuretic peptide infusion on kidney function in normotensive type 1 (insulin-dependent) diabetic patients before and after enalapril treatment. 69
Renal structure in type 2 diabetic patients with microalbuminuria 68
Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. 68
CELLULAR BASIS OF DIABETIC NEPHROPATHY: IV ANTIOXIDANT ENZYME MRNA EXPRESSION LEVELS IN SKIN FIBROBLASTS OF TYPE 1 DIABETIC SIBLING PAIRS. 67
Residual macrovascular risk in 2013: what have we learned? 67
Ketone body metabolism: a physiological and clinical overview. 67
Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. 66
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 66
The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes 65
Substrate availability other than glucose in the brain during euglycemia and insulin-induced hypo¬glycemia in dogs. 65
Effects of pancreas transplantation on the prevention and reversal of diabetic nephropathy 65
Diabetic nephropathy: challenges in pathologic classification.Nat Rev Nephrol (Prec Nat Clin Pract Nephrol), 6: 508-510, 2010 64
Totale 8.432
Categoria #
all - tutte 41.862
article - articoli 39.404
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.735
Totale 83.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.196 0 0 0 0 0 0 0 0 19 233 457 487
2019/20203.007 488 111 63 266 324 235 271 366 299 235 202 147
2020/20212.382 97 165 142 316 153 164 75 203 345 178 287 257
2021/20222.447 98 283 255 193 148 120 104 264 128 68 246 540
2022/20231.643 466 136 21 142 307 205 2 112 172 12 52 16
2023/2024648 32 119 80 72 69 139 75 45 17 0 0 0
Totale 13.568